BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2205386, encodeId=85652205386b8, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学;生物信息学;肿瘤 经验分享：23.10.28 首次投稿 24.1.19 返回2个审稿意见要求补充一点分析，算是小修，给了8周时间 24.2.24 修回 24.3.16 接收 24.4.11 proof 24.4.15 online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bad8649258, createdName=ms1000001760489592, createdTime=Sat May 18 16:47:42 CST 2024, time=2024-05-18, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=1088045, encodeId=b83e1088045eb, content=怎么撰写引言？区别于讨论？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088046, encodeId=88f91088046ff, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569410, encodeId=993956941069, content=18年底的已经发了，审稿很严格，效率很高。毛毛1992 2017-03-21 发表:: 研究方向：靶向给药;菌膜; 接收率：约25% 审稿时间：约2个月 SCI(2015)：1.429 审了20天状态终于从pending assign editor变成了under review 不知道是有审稿人开始审稿了还是仅仅只是编剧点开了看一下不过我看这个杂志已经积压了很多稿件了现在还在发15年接收的稿子估计很悬毛毛1992 2017-03-21 09:33:00 发表: 审了20天状态终于从pending assign editor变成了under review 不知道是有审稿人开始审稿了还是仅仅只是编剧点开了看一下不过我看这个杂志已经积压了很多稿件了现在还在发15年接收的稿子估计很悬, beContent=毛毛1992 2017-03-21 发表:: 研究方向：靶向给药;菌膜; 接收率：约25% 审稿时间：约2个月 SCI(2015)：1.429 审了20天状态终于从pending assign editor变成了under review 不知道是有审稿人开始审稿了还是仅仅只是编剧点开了看一下不过我看这个杂志已经积压了很多稿件了现在还在发15年接收的稿子估计很悬, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/10/817fff867869bdbb384cc9b009479e6e.jpg, createdBy=c3d240708, createdName=quan12zf, createdTime=Thu Apr 11 00:00:00 CST 2019, time=2019-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839634, encodeId=182283963489, content=巨慢，而且给编辑写过几次信都是石沉大海。with editor状态就大概一个月，问什么时候送审没有回信，第二次是投稿3个多月的时候询问结果，也没有收到回复。四个月后终于来意见让修改，8周的修改期限，快到期时写信申请延期也没有回信。由于要求补实验数据还要送到专业机构润色语言，改了差不多三个月，修回时由于系统里面提交修改稿的通道已经关闭，只好作为新稿件提交，谁知提交后马上就收到邮件说请不要作为新稿件提交，同时给开通了原稿件的提交修改稿通道。修回后又等了将近一个月才接收。总之，如果不着急又没有更合适的期刊的可以投这个，要是着急等着用文章毕业的，这个期刊急死你没商量，而且催也不搭理的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=747c5414139, createdName=ms8486473624116251, createdTime=Thu Nov 30 10:51:14 CST 2017, time=2017-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541288, encodeId=7cc5541288f0, content=马马虎虎，能毕业就行，我师兄去年发表了一篇，也算成功毕业，就万事大吉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=huabing, createdTime=Fri Jul 14 18:46:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534499, encodeId=ba1453449929, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：审了20天状态终于从pending assign editor变成了under review 不知道是有审稿人开始审稿了还是仅仅只是编剧点开了看一下不过我看这个杂志已经积压了很多稿件了现在还在发15年接收的稿子估计很悬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d8fa1676916, createdName=毛毛1992, createdTime=Tue Mar 21 09:33:00 CST 2017, time=2017-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519663, encodeId=4a7751966325, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：2015/10/22投稿次日under review，到现在一直是under review，已经5个多月了，审稿不是一般的慢，不建议大家投该杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3b61629813, createdName=chunji1990, createdTime=Sat Feb 27 10:09:00 CST 2016, time=2016-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518883, encodeId=f52e5188838b, content=楼下说的上海的教授应该就是上海交大的钟建江老师。这位老师还是很严谨的一个老师，也比较客观公正。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa331680241, createdName=yuanfen123, createdTime=Fri Jan 29 17:46:00 CST 2016, time=2016-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505532, encodeId=7d7f50553268, content=审稿速度:2.0 经验分享：7月13日投稿，8月21日大修。三个审稿人，总共11条意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=353, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200811/5cde539c2b5a4674a6479f294173176f/e76541cf0e0f4a2188730c98d2e6be92.jpg, createdBy=ad4d88222, createdName=dswjhs, createdTime=Sat Aug 23 12:23:00 CST 2014, time=2014-08-23, status=1, ipAttribution=)]

2024-05-18 ms1000001760489592 来自新加坡

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：分子生物学;生物信息学;肿瘤
经验分享：23.10.28 首次投稿
24.1.19 返回2个审稿意见要求补充一点分析，算是小修，给了8周时间
24.2.24 修回
24.3.16 接收
24.4.11 proof
24.4.15 online

35 0

[GetPortalCommentsPageByObjectIdResponse(id=2205386, encodeId=85652205386b8, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学;生物信息学;肿瘤 经验分享：23.10.28 首次投稿 24.1.19 返回2个审稿意见要求补充一点分析，算是小修，给了8周时间 24.2.24 修回 24.3.16 接收 24.4.11 proof 24.4.15 online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bad8649258, createdName=ms1000001760489592, createdTime=Sat May 18 16:47:42 CST 2024, time=2024-05-18, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=1088045, encodeId=b83e1088045eb, content=怎么撰写引言？区别于讨论？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088046, encodeId=88f91088046ff, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569410, encodeId=993956941069, content=18年底的已经发了，审稿很严格，效率很高。毛毛1992 2017-03-21 发表:: 研究方向：靶向给药;菌膜; 接收率：约25% 审稿时间：约2个月 SCI(2015)：1.429 审了20天状态终于从pending assign editor变成了under review 不知道是有审稿人开始审稿了还是仅仅只是编剧点开了看一下不过我看这个杂志已经积压了很多稿件了现在还在发15年接收的稿子估计很悬毛毛1992 2017-03-21 09:33:00 发表: 审了20天状态终于从pending assign editor变成了under review 不知道是有审稿人开始审稿了还是仅仅只是编剧点开了看一下不过我看这个杂志已经积压了很多稿件了现在还在发15年接收的稿子估计很悬, beContent=毛毛1992 2017-03-21 发表:: 研究方向：靶向给药;菌膜; 接收率：约25% 审稿时间：约2个月 SCI(2015)：1.429 审了20天状态终于从pending assign editor变成了under review 不知道是有审稿人开始审稿了还是仅仅只是编剧点开了看一下不过我看这个杂志已经积压了很多稿件了现在还在发15年接收的稿子估计很悬, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/10/817fff867869bdbb384cc9b009479e6e.jpg, createdBy=c3d240708, createdName=quan12zf, createdTime=Thu Apr 11 00:00:00 CST 2019, time=2019-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839634, encodeId=182283963489, content=巨慢，而且给编辑写过几次信都是石沉大海。with editor状态就大概一个月，问什么时候送审没有回信，第二次是投稿3个多月的时候询问结果，也没有收到回复。四个月后终于来意见让修改，8周的修改期限，快到期时写信申请延期也没有回信。由于要求补实验数据还要送到专业机构润色语言，改了差不多三个月，修回时由于系统里面提交修改稿的通道已经关闭，只好作为新稿件提交，谁知提交后马上就收到邮件说请不要作为新稿件提交，同时给开通了原稿件的提交修改稿通道。修回后又等了将近一个月才接收。总之，如果不着急又没有更合适的期刊的可以投这个，要是着急等着用文章毕业的，这个期刊急死你没商量，而且催也不搭理的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=747c5414139, createdName=ms8486473624116251, createdTime=Thu Nov 30 10:51:14 CST 2017, time=2017-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541288, encodeId=7cc5541288f0, content=马马虎虎，能毕业就行，我师兄去年发表了一篇，也算成功毕业，就万事大吉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=huabing, createdTime=Fri Jul 14 18:46:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534499, encodeId=ba1453449929, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：审了20天状态终于从pending assign editor变成了under review 不知道是有审稿人开始审稿了还是仅仅只是编剧点开了看一下不过我看这个杂志已经积压了很多稿件了现在还在发15年接收的稿子估计很悬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d8fa1676916, createdName=毛毛1992, createdTime=Tue Mar 21 09:33:00 CST 2017, time=2017-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519663, encodeId=4a7751966325, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：2015/10/22投稿次日under review，到现在一直是under review，已经5个多月了，审稿不是一般的慢，不建议大家投该杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3b61629813, createdName=chunji1990, createdTime=Sat Feb 27 10:09:00 CST 2016, time=2016-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518883, encodeId=f52e5188838b, content=楼下说的上海的教授应该就是上海交大的钟建江老师。这位老师还是很严谨的一个老师，也比较客观公正。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa331680241, createdName=yuanfen123, createdTime=Fri Jan 29 17:46:00 CST 2016, time=2016-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505532, encodeId=7d7f50553268, content=审稿速度:2.0 经验分享：7月13日投稿，8月21日大修。三个审稿人，总共11条意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=353, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200811/5cde539c2b5a4674a6479f294173176f/e76541cf0e0f4a2188730c98d2e6be92.jpg, createdBy=ad4d88222, createdName=dswjhs, createdTime=Sat Aug 23 12:23:00 CST 2014, time=2014-08-23, status=1, ipAttribution=)]

2021-12-28 小动量

怎么撰写引言？区别于讨论？

69 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2205386, encodeId=85652205386b8, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学;生物信息学;肿瘤 经验分享：23.10.28 首次投稿 24.1.19 返回2个审稿意见要求补充一点分析，算是小修，给了8周时间 24.2.24 修回 24.3.16 接收 24.4.11 proof 24.4.15 online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bad8649258, createdName=ms1000001760489592, createdTime=Sat May 18 16:47:42 CST 2024, time=2024-05-18, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=1088045, encodeId=b83e1088045eb, content=怎么撰写引言？区别于讨论？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088046, encodeId=88f91088046ff, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569410, encodeId=993956941069, content=18年底的已经发了，审稿很严格，效率很高。毛毛1992 2017-03-21 发表:: 研究方向：靶向给药;菌膜; 接收率：约25% 审稿时间：约2个月 SCI(2015)：1.429 审了20天状态终于从pending assign editor变成了under review 不知道是有审稿人开始审稿了还是仅仅只是编剧点开了看一下不过我看这个杂志已经积压了很多稿件了现在还在发15年接收的稿子估计很悬毛毛1992 2017-03-21 09:33:00 发表: 审了20天状态终于从pending assign editor变成了under review 不知道是有审稿人开始审稿了还是仅仅只是编剧点开了看一下不过我看这个杂志已经积压了很多稿件了现在还在发15年接收的稿子估计很悬, beContent=毛毛1992 2017-03-21 发表:: 研究方向：靶向给药;菌膜; 接收率：约25% 审稿时间：约2个月 SCI(2015)：1.429 审了20天状态终于从pending assign editor变成了under review 不知道是有审稿人开始审稿了还是仅仅只是编剧点开了看一下不过我看这个杂志已经积压了很多稿件了现在还在发15年接收的稿子估计很悬, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/10/817fff867869bdbb384cc9b009479e6e.jpg, createdBy=c3d240708, createdName=quan12zf, createdTime=Thu Apr 11 00:00:00 CST 2019, time=2019-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839634, encodeId=182283963489, content=巨慢，而且给编辑写过几次信都是石沉大海。with editor状态就大概一个月，问什么时候送审没有回信，第二次是投稿3个多月的时候询问结果，也没有收到回复。四个月后终于来意见让修改，8周的修改期限，快到期时写信申请延期也没有回信。由于要求补实验数据还要送到专业机构润色语言，改了差不多三个月，修回时由于系统里面提交修改稿的通道已经关闭，只好作为新稿件提交，谁知提交后马上就收到邮件说请不要作为新稿件提交，同时给开通了原稿件的提交修改稿通道。修回后又等了将近一个月才接收。总之，如果不着急又没有更合适的期刊的可以投这个，要是着急等着用文章毕业的，这个期刊急死你没商量，而且催也不搭理的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=747c5414139, createdName=ms8486473624116251, createdTime=Thu Nov 30 10:51:14 CST 2017, time=2017-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541288, encodeId=7cc5541288f0, content=马马虎虎，能毕业就行，我师兄去年发表了一篇，也算成功毕业，就万事大吉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=huabing, createdTime=Fri Jul 14 18:46:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534499, encodeId=ba1453449929, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：审了20天状态终于从pending assign editor变成了under review 不知道是有审稿人开始审稿了还是仅仅只是编剧点开了看一下不过我看这个杂志已经积压了很多稿件了现在还在发15年接收的稿子估计很悬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d8fa1676916, createdName=毛毛1992, createdTime=Tue Mar 21 09:33:00 CST 2017, time=2017-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519663, encodeId=4a7751966325, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：2015/10/22投稿次日under review，到现在一直是under review，已经5个多月了，审稿不是一般的慢，不建议大家投该杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3b61629813, createdName=chunji1990, createdTime=Sat Feb 27 10:09:00 CST 2016, time=2016-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518883, encodeId=f52e5188838b, content=楼下说的上海的教授应该就是上海交大的钟建江老师。这位老师还是很严谨的一个老师，也比较客观公正。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa331680241, createdName=yuanfen123, createdTime=Fri Jan 29 17:46:00 CST 2016, time=2016-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505532, encodeId=7d7f50553268, content=审稿速度:2.0 经验分享：7月13日投稿，8月21日大修。三个审稿人，总共11条意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=353, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200811/5cde539c2b5a4674a6479f294173176f/e76541cf0e0f4a2188730c98d2e6be92.jpg, createdBy=ad4d88222, createdName=dswjhs, createdTime=Sat Aug 23 12:23:00 CST 2014, time=2014-08-23, status=1, ipAttribution=)]

2021-12-27 msSSSSSD

引言和讨论如何写的不重复？

71 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2205386, encodeId=85652205386b8, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学;生物信息学;肿瘤 经验分享：23.10.28 首次投稿 24.1.19 返回2个审稿意见要求补充一点分析，算是小修，给了8周时间 24.2.24 修回 24.3.16 接收 24.4.11 proof 24.4.15 online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bad8649258, createdName=ms1000001760489592, createdTime=Sat May 18 16:47:42 CST 2024, time=2024-05-18, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=1088045, encodeId=b83e1088045eb, content=怎么撰写引言？区别于讨论？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088046, encodeId=88f91088046ff, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569410, encodeId=993956941069, content=18年底的已经发了，审稿很严格，效率很高。毛毛1992 2017-03-21 发表:: 研究方向：靶向给药;菌膜; 接收率：约25% 审稿时间：约2个月 SCI(2015)：1.429 审了20天状态终于从pending assign editor变成了under review 不知道是有审稿人开始审稿了还是仅仅只是编剧点开了看一下不过我看这个杂志已经积压了很多稿件了现在还在发15年接收的稿子估计很悬毛毛1992 2017-03-21 09:33:00 发表: 审了20天状态终于从pending assign editor变成了under review 不知道是有审稿人开始审稿了还是仅仅只是编剧点开了看一下不过我看这个杂志已经积压了很多稿件了现在还在发15年接收的稿子估计很悬, beContent=毛毛1992 2017-03-21 发表:: 研究方向：靶向给药;菌膜; 接收率：约25% 审稿时间：约2个月 SCI(2015)：1.429 审了20天状态终于从pending assign editor变成了under review 不知道是有审稿人开始审稿了还是仅仅只是编剧点开了看一下不过我看这个杂志已经积压了很多稿件了现在还在发15年接收的稿子估计很悬, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/10/817fff867869bdbb384cc9b009479e6e.jpg, createdBy=c3d240708, createdName=quan12zf, createdTime=Thu Apr 11 00:00:00 CST 2019, time=2019-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839634, encodeId=182283963489, content=巨慢，而且给编辑写过几次信都是石沉大海。with editor状态就大概一个月，问什么时候送审没有回信，第二次是投稿3个多月的时候询问结果，也没有收到回复。四个月后终于来意见让修改，8周的修改期限，快到期时写信申请延期也没有回信。由于要求补实验数据还要送到专业机构润色语言，改了差不多三个月，修回时由于系统里面提交修改稿的通道已经关闭，只好作为新稿件提交，谁知提交后马上就收到邮件说请不要作为新稿件提交，同时给开通了原稿件的提交修改稿通道。修回后又等了将近一个月才接收。总之，如果不着急又没有更合适的期刊的可以投这个，要是着急等着用文章毕业的，这个期刊急死你没商量，而且催也不搭理的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=747c5414139, createdName=ms8486473624116251, createdTime=Thu Nov 30 10:51:14 CST 2017, time=2017-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541288, encodeId=7cc5541288f0, content=马马虎虎，能毕业就行，我师兄去年发表了一篇，也算成功毕业，就万事大吉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=huabing, createdTime=Fri Jul 14 18:46:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534499, encodeId=ba1453449929, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：审了20天状态终于从pending assign editor变成了under review 不知道是有审稿人开始审稿了还是仅仅只是编剧点开了看一下不过我看这个杂志已经积压了很多稿件了现在还在发15年接收的稿子估计很悬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d8fa1676916, createdName=毛毛1992, createdTime=Tue Mar 21 09:33:00 CST 2017, time=2017-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519663, encodeId=4a7751966325, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：2015/10/22投稿次日under review，到现在一直是under review，已经5个多月了，审稿不是一般的慢，不建议大家投该杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3b61629813, createdName=chunji1990, createdTime=Sat Feb 27 10:09:00 CST 2016, time=2016-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518883, encodeId=f52e5188838b, content=楼下说的上海的教授应该就是上海交大的钟建江老师。这位老师还是很严谨的一个老师，也比较客观公正。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa331680241, createdName=yuanfen123, createdTime=Fri Jan 29 17:46:00 CST 2016, time=2016-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505532, encodeId=7d7f50553268, content=审稿速度:2.0 经验分享：7月13日投稿，8月21日大修。三个审稿人，总共11条意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=353, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200811/5cde539c2b5a4674a6479f294173176f/e76541cf0e0f4a2188730c98d2e6be92.jpg, createdBy=ad4d88222, createdName=dswjhs, createdTime=Sat Aug 23 12:23:00 CST 2014, time=2014-08-23, status=1, ipAttribution=)]

2019-04-11 quan12zf

18年底的已经发了，审稿很严格，效率很高。毛毛1992 2017-03-21 发表::
研究方向：靶向给药;菌膜; 接收率：约25% 审稿时间：约2个月 SCI(2015)：1.429 审了20天状态终于从pending assign editor变成了under review 不知道是有审稿人开始审稿了还是仅仅只是编剧点开了看一下不过我看这个杂志已经积压了很多稿件了现在还在发15年接收的稿子估计很悬毛毛1992 2017-03-21 09:33:00 发表:
审了20天状态终于从pending assign editor变成了under review 不知道是有审稿人开始审稿了还是仅仅只是编剧点开了看一下不过我看这个杂志已经积压了很多稿件了现在还在发15年接收的稿子估计很悬

毛毛1992 2017-03-21 发表:: 研究方向：靶向给药;菌膜; 接收率：约25% 审稿时间：约2个月 SCI(2015)：1.429 审了20天状态终于从pending assign editor变成了under review 不知道是有审稿人开始审稿了还是仅仅只是编剧点开了看一下不过我看这个杂志已经积压了很多稿件了现在还在发15年接收的稿子估计很悬

168 0

[GetPortalCommentsPageByObjectIdResponse(id=2205386, encodeId=85652205386b8, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学;生物信息学;肿瘤 经验分享：23.10.28 首次投稿 24.1.19 返回2个审稿意见要求补充一点分析，算是小修，给了8周时间 24.2.24 修回 24.3.16 接收 24.4.11 proof 24.4.15 online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bad8649258, createdName=ms1000001760489592, createdTime=Sat May 18 16:47:42 CST 2024, time=2024-05-18, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=1088045, encodeId=b83e1088045eb, content=怎么撰写引言？区别于讨论？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088046, encodeId=88f91088046ff, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569410, encodeId=993956941069, content=18年底的已经发了，审稿很严格，效率很高。毛毛1992 2017-03-21 发表:: 研究方向：靶向给药;菌膜; 接收率：约25% 审稿时间：约2个月 SCI(2015)：1.429 审了20天状态终于从pending assign editor变成了under review 不知道是有审稿人开始审稿了还是仅仅只是编剧点开了看一下不过我看这个杂志已经积压了很多稿件了现在还在发15年接收的稿子估计很悬毛毛1992 2017-03-21 09:33:00 发表: 审了20天状态终于从pending assign editor变成了under review 不知道是有审稿人开始审稿了还是仅仅只是编剧点开了看一下不过我看这个杂志已经积压了很多稿件了现在还在发15年接收的稿子估计很悬, beContent=毛毛1992 2017-03-21 发表:: 研究方向：靶向给药;菌膜; 接收率：约25% 审稿时间：约2个月 SCI(2015)：1.429 审了20天状态终于从pending assign editor变成了under review 不知道是有审稿人开始审稿了还是仅仅只是编剧点开了看一下不过我看这个杂志已经积压了很多稿件了现在还在发15年接收的稿子估计很悬, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/10/817fff867869bdbb384cc9b009479e6e.jpg, createdBy=c3d240708, createdName=quan12zf, createdTime=Thu Apr 11 00:00:00 CST 2019, time=2019-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839634, encodeId=182283963489, content=巨慢，而且给编辑写过几次信都是石沉大海。with editor状态就大概一个月，问什么时候送审没有回信，第二次是投稿3个多月的时候询问结果，也没有收到回复。四个月后终于来意见让修改，8周的修改期限，快到期时写信申请延期也没有回信。由于要求补实验数据还要送到专业机构润色语言，改了差不多三个月，修回时由于系统里面提交修改稿的通道已经关闭，只好作为新稿件提交，谁知提交后马上就收到邮件说请不要作为新稿件提交，同时给开通了原稿件的提交修改稿通道。修回后又等了将近一个月才接收。总之，如果不着急又没有更合适的期刊的可以投这个，要是着急等着用文章毕业的，这个期刊急死你没商量，而且催也不搭理的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=747c5414139, createdName=ms8486473624116251, createdTime=Thu Nov 30 10:51:14 CST 2017, time=2017-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541288, encodeId=7cc5541288f0, content=马马虎虎，能毕业就行，我师兄去年发表了一篇，也算成功毕业，就万事大吉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=huabing, createdTime=Fri Jul 14 18:46:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534499, encodeId=ba1453449929, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：审了20天状态终于从pending assign editor变成了under review 不知道是有审稿人开始审稿了还是仅仅只是编剧点开了看一下不过我看这个杂志已经积压了很多稿件了现在还在发15年接收的稿子估计很悬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d8fa1676916, createdName=毛毛1992, createdTime=Tue Mar 21 09:33:00 CST 2017, time=2017-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519663, encodeId=4a7751966325, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：2015/10/22投稿次日under review，到现在一直是under review，已经5个多月了，审稿不是一般的慢，不建议大家投该杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3b61629813, createdName=chunji1990, createdTime=Sat Feb 27 10:09:00 CST 2016, time=2016-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518883, encodeId=f52e5188838b, content=楼下说的上海的教授应该就是上海交大的钟建江老师。这位老师还是很严谨的一个老师，也比较客观公正。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa331680241, createdName=yuanfen123, createdTime=Fri Jan 29 17:46:00 CST 2016, time=2016-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505532, encodeId=7d7f50553268, content=审稿速度:2.0 经验分享：7月13日投稿，8月21日大修。三个审稿人，总共11条意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=353, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200811/5cde539c2b5a4674a6479f294173176f/e76541cf0e0f4a2188730c98d2e6be92.jpg, createdBy=ad4d88222, createdName=dswjhs, createdTime=Sat Aug 23 12:23:00 CST 2014, time=2014-08-23, status=1, ipAttribution=)]

2017-11-30 ms8486473624116251

巨慢，而且给编辑写过几次信都是石沉大海。with editor状态就大概一个月，问什么时候送审没有回信，第二次是投稿3个多月的时候询问结果，也没有收到回复。四个月后终于来意见让修改，8周的修改期限，快到期时写信申请延期也没有回信。由于要求补实验数据还要送到专业机构润色语言，改了差不多三个月，修回时由于系统里面提交修改稿的通道已经关闭，只好作为新稿件提交，谁知提交后马上就收到邮件说请不要作为新稿件提交，同时给开通了原稿件的提交修改稿通道。修回后又等了将近一个月才接收。总之，如果不着急又没有更合适的期刊的可以投这个，要是着急等着用文章毕业的，这个期刊急死你没商量，而且催也不搭理的。

0 0

[GetPortalCommentsPageByObjectIdResponse(id=2205386, encodeId=85652205386b8, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学;生物信息学;肿瘤 经验分享：23.10.28 首次投稿 24.1.19 返回2个审稿意见要求补充一点分析，算是小修，给了8周时间 24.2.24 修回 24.3.16 接收 24.4.11 proof 24.4.15 online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bad8649258, createdName=ms1000001760489592, createdTime=Sat May 18 16:47:42 CST 2024, time=2024-05-18, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=1088045, encodeId=b83e1088045eb, content=怎么撰写引言？区别于讨论？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088046, encodeId=88f91088046ff, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569410, encodeId=993956941069, content=18年底的已经发了，审稿很严格，效率很高。毛毛1992 2017-03-21 发表:: 研究方向：靶向给药;菌膜; 接收率：约25% 审稿时间：约2个月 SCI(2015)：1.429 审了20天状态终于从pending assign editor变成了under review 不知道是有审稿人开始审稿了还是仅仅只是编剧点开了看一下不过我看这个杂志已经积压了很多稿件了现在还在发15年接收的稿子估计很悬毛毛1992 2017-03-21 09:33:00 发表: 审了20天状态终于从pending assign editor变成了under review 不知道是有审稿人开始审稿了还是仅仅只是编剧点开了看一下不过我看这个杂志已经积压了很多稿件了现在还在发15年接收的稿子估计很悬, beContent=毛毛1992 2017-03-21 发表:: 研究方向：靶向给药;菌膜; 接收率：约25% 审稿时间：约2个月 SCI(2015)：1.429 审了20天状态终于从pending assign editor变成了under review 不知道是有审稿人开始审稿了还是仅仅只是编剧点开了看一下不过我看这个杂志已经积压了很多稿件了现在还在发15年接收的稿子估计很悬, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/10/817fff867869bdbb384cc9b009479e6e.jpg, createdBy=c3d240708, createdName=quan12zf, createdTime=Thu Apr 11 00:00:00 CST 2019, time=2019-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839634, encodeId=182283963489, content=巨慢，而且给编辑写过几次信都是石沉大海。with editor状态就大概一个月，问什么时候送审没有回信，第二次是投稿3个多月的时候询问结果，也没有收到回复。四个月后终于来意见让修改，8周的修改期限，快到期时写信申请延期也没有回信。由于要求补实验数据还要送到专业机构润色语言，改了差不多三个月，修回时由于系统里面提交修改稿的通道已经关闭，只好作为新稿件提交，谁知提交后马上就收到邮件说请不要作为新稿件提交，同时给开通了原稿件的提交修改稿通道。修回后又等了将近一个月才接收。总之，如果不着急又没有更合适的期刊的可以投这个，要是着急等着用文章毕业的，这个期刊急死你没商量，而且催也不搭理的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=747c5414139, createdName=ms8486473624116251, createdTime=Thu Nov 30 10:51:14 CST 2017, time=2017-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541288, encodeId=7cc5541288f0, content=马马虎虎，能毕业就行，我师兄去年发表了一篇，也算成功毕业，就万事大吉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=huabing, createdTime=Fri Jul 14 18:46:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534499, encodeId=ba1453449929, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：审了20天状态终于从pending assign editor变成了under review 不知道是有审稿人开始审稿了还是仅仅只是编剧点开了看一下不过我看这个杂志已经积压了很多稿件了现在还在发15年接收的稿子估计很悬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d8fa1676916, createdName=毛毛1992, createdTime=Tue Mar 21 09:33:00 CST 2017, time=2017-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519663, encodeId=4a7751966325, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：2015/10/22投稿次日under review，到现在一直是under review，已经5个多月了，审稿不是一般的慢，不建议大家投该杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3b61629813, createdName=chunji1990, createdTime=Sat Feb 27 10:09:00 CST 2016, time=2016-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518883, encodeId=f52e5188838b, content=楼下说的上海的教授应该就是上海交大的钟建江老师。这位老师还是很严谨的一个老师，也比较客观公正。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa331680241, createdName=yuanfen123, createdTime=Fri Jan 29 17:46:00 CST 2016, time=2016-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505532, encodeId=7d7f50553268, content=审稿速度:2.0 经验分享：7月13日投稿，8月21日大修。三个审稿人，总共11条意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=353, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200811/5cde539c2b5a4674a6479f294173176f/e76541cf0e0f4a2188730c98d2e6be92.jpg, createdBy=ad4d88222, createdName=dswjhs, createdTime=Sat Aug 23 12:23:00 CST 2014, time=2014-08-23, status=1, ipAttribution=)]

2017-07-14 huabing

马马虎虎，能毕业就行，我师兄去年发表了一篇，也算成功毕业，就万事大吉了

355 0

[GetPortalCommentsPageByObjectIdResponse(id=2205386, encodeId=85652205386b8, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学;生物信息学;肿瘤 经验分享：23.10.28 首次投稿 24.1.19 返回2个审稿意见要求补充一点分析，算是小修，给了8周时间 24.2.24 修回 24.3.16 接收 24.4.11 proof 24.4.15 online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bad8649258, createdName=ms1000001760489592, createdTime=Sat May 18 16:47:42 CST 2024, time=2024-05-18, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=1088045, encodeId=b83e1088045eb, content=怎么撰写引言？区别于讨论？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088046, encodeId=88f91088046ff, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569410, encodeId=993956941069, content=18年底的已经发了，审稿很严格，效率很高。毛毛1992 2017-03-21 发表:: 研究方向：靶向给药;菌膜; 接收率：约25% 审稿时间：约2个月 SCI(2015)：1.429 审了20天状态终于从pending assign editor变成了under review 不知道是有审稿人开始审稿了还是仅仅只是编剧点开了看一下不过我看这个杂志已经积压了很多稿件了现在还在发15年接收的稿子估计很悬毛毛1992 2017-03-21 09:33:00 发表: 审了20天状态终于从pending assign editor变成了under review 不知道是有审稿人开始审稿了还是仅仅只是编剧点开了看一下不过我看这个杂志已经积压了很多稿件了现在还在发15年接收的稿子估计很悬, beContent=毛毛1992 2017-03-21 发表:: 研究方向：靶向给药;菌膜; 接收率：约25% 审稿时间：约2个月 SCI(2015)：1.429 审了20天状态终于从pending assign editor变成了under review 不知道是有审稿人开始审稿了还是仅仅只是编剧点开了看一下不过我看这个杂志已经积压了很多稿件了现在还在发15年接收的稿子估计很悬, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/10/817fff867869bdbb384cc9b009479e6e.jpg, createdBy=c3d240708, createdName=quan12zf, createdTime=Thu Apr 11 00:00:00 CST 2019, time=2019-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839634, encodeId=182283963489, content=巨慢，而且给编辑写过几次信都是石沉大海。with editor状态就大概一个月，问什么时候送审没有回信，第二次是投稿3个多月的时候询问结果，也没有收到回复。四个月后终于来意见让修改，8周的修改期限，快到期时写信申请延期也没有回信。由于要求补实验数据还要送到专业机构润色语言，改了差不多三个月，修回时由于系统里面提交修改稿的通道已经关闭，只好作为新稿件提交，谁知提交后马上就收到邮件说请不要作为新稿件提交，同时给开通了原稿件的提交修改稿通道。修回后又等了将近一个月才接收。总之，如果不着急又没有更合适的期刊的可以投这个，要是着急等着用文章毕业的，这个期刊急死你没商量，而且催也不搭理的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=747c5414139, createdName=ms8486473624116251, createdTime=Thu Nov 30 10:51:14 CST 2017, time=2017-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541288, encodeId=7cc5541288f0, content=马马虎虎，能毕业就行，我师兄去年发表了一篇，也算成功毕业，就万事大吉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=huabing, createdTime=Fri Jul 14 18:46:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534499, encodeId=ba1453449929, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：审了20天状态终于从pending assign editor变成了under review 不知道是有审稿人开始审稿了还是仅仅只是编剧点开了看一下不过我看这个杂志已经积压了很多稿件了现在还在发15年接收的稿子估计很悬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d8fa1676916, createdName=毛毛1992, createdTime=Tue Mar 21 09:33:00 CST 2017, time=2017-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519663, encodeId=4a7751966325, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：2015/10/22投稿次日under review，到现在一直是under review，已经5个多月了，审稿不是一般的慢，不建议大家投该杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3b61629813, createdName=chunji1990, createdTime=Sat Feb 27 10:09:00 CST 2016, time=2016-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518883, encodeId=f52e5188838b, content=楼下说的上海的教授应该就是上海交大的钟建江老师。这位老师还是很严谨的一个老师，也比较客观公正。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa331680241, createdName=yuanfen123, createdTime=Fri Jan 29 17:46:00 CST 2016, time=2016-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505532, encodeId=7d7f50553268, content=审稿速度:2.0 经验分享：7月13日投稿，8月21日大修。三个审稿人，总共11条意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=353, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200811/5cde539c2b5a4674a6479f294173176f/e76541cf0e0f4a2188730c98d2e6be92.jpg, createdBy=ad4d88222, createdName=dswjhs, createdTime=Sat Aug 23 12:23:00 CST 2014, time=2014-08-23, status=1, ipAttribution=)]

2017-03-21 毛毛1992

审稿速度:2.0 | 投稿命中率:25.0
经验分享：审了20天状态终于从pending assign editor变成了under review 不知道是有审稿人开始审稿了还是仅仅只是编剧点开了看一下不过我看这个杂志已经积压了很多稿件了现在还在发15年接收的稿子估计很悬

291 0

[GetPortalCommentsPageByObjectIdResponse(id=2205386, encodeId=85652205386b8, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学;生物信息学;肿瘤 经验分享：23.10.28 首次投稿 24.1.19 返回2个审稿意见要求补充一点分析，算是小修，给了8周时间 24.2.24 修回 24.3.16 接收 24.4.11 proof 24.4.15 online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bad8649258, createdName=ms1000001760489592, createdTime=Sat May 18 16:47:42 CST 2024, time=2024-05-18, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=1088045, encodeId=b83e1088045eb, content=怎么撰写引言？区别于讨论？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088046, encodeId=88f91088046ff, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569410, encodeId=993956941069, content=18年底的已经发了，审稿很严格，效率很高。毛毛1992 2017-03-21 发表:: 研究方向：靶向给药;菌膜; 接收率：约25% 审稿时间：约2个月 SCI(2015)：1.429 审了20天状态终于从pending assign editor变成了under review 不知道是有审稿人开始审稿了还是仅仅只是编剧点开了看一下不过我看这个杂志已经积压了很多稿件了现在还在发15年接收的稿子估计很悬毛毛1992 2017-03-21 09:33:00 发表: 审了20天状态终于从pending assign editor变成了under review 不知道是有审稿人开始审稿了还是仅仅只是编剧点开了看一下不过我看这个杂志已经积压了很多稿件了现在还在发15年接收的稿子估计很悬, beContent=毛毛1992 2017-03-21 发表:: 研究方向：靶向给药;菌膜; 接收率：约25% 审稿时间：约2个月 SCI(2015)：1.429 审了20天状态终于从pending assign editor变成了under review 不知道是有审稿人开始审稿了还是仅仅只是编剧点开了看一下不过我看这个杂志已经积压了很多稿件了现在还在发15年接收的稿子估计很悬, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/10/817fff867869bdbb384cc9b009479e6e.jpg, createdBy=c3d240708, createdName=quan12zf, createdTime=Thu Apr 11 00:00:00 CST 2019, time=2019-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839634, encodeId=182283963489, content=巨慢，而且给编辑写过几次信都是石沉大海。with editor状态就大概一个月，问什么时候送审没有回信，第二次是投稿3个多月的时候询问结果，也没有收到回复。四个月后终于来意见让修改，8周的修改期限，快到期时写信申请延期也没有回信。由于要求补实验数据还要送到专业机构润色语言，改了差不多三个月，修回时由于系统里面提交修改稿的通道已经关闭，只好作为新稿件提交，谁知提交后马上就收到邮件说请不要作为新稿件提交，同时给开通了原稿件的提交修改稿通道。修回后又等了将近一个月才接收。总之，如果不着急又没有更合适的期刊的可以投这个，要是着急等着用文章毕业的，这个期刊急死你没商量，而且催也不搭理的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=747c5414139, createdName=ms8486473624116251, createdTime=Thu Nov 30 10:51:14 CST 2017, time=2017-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541288, encodeId=7cc5541288f0, content=马马虎虎，能毕业就行，我师兄去年发表了一篇，也算成功毕业，就万事大吉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=huabing, createdTime=Fri Jul 14 18:46:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534499, encodeId=ba1453449929, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：审了20天状态终于从pending assign editor变成了under review 不知道是有审稿人开始审稿了还是仅仅只是编剧点开了看一下不过我看这个杂志已经积压了很多稿件了现在还在发15年接收的稿子估计很悬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d8fa1676916, createdName=毛毛1992, createdTime=Tue Mar 21 09:33:00 CST 2017, time=2017-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519663, encodeId=4a7751966325, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：2015/10/22投稿次日under review，到现在一直是under review，已经5个多月了，审稿不是一般的慢，不建议大家投该杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3b61629813, createdName=chunji1990, createdTime=Sat Feb 27 10:09:00 CST 2016, time=2016-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518883, encodeId=f52e5188838b, content=楼下说的上海的教授应该就是上海交大的钟建江老师。这位老师还是很严谨的一个老师，也比较客观公正。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa331680241, createdName=yuanfen123, createdTime=Fri Jan 29 17:46:00 CST 2016, time=2016-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505532, encodeId=7d7f50553268, content=审稿速度:2.0 经验分享：7月13日投稿，8月21日大修。三个审稿人，总共11条意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=353, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200811/5cde539c2b5a4674a6479f294173176f/e76541cf0e0f4a2188730c98d2e6be92.jpg, createdBy=ad4d88222, createdName=dswjhs, createdTime=Sat Aug 23 12:23:00 CST 2014, time=2014-08-23, status=1, ipAttribution=)]

2016-02-27 chunji1990

审稿速度:6.0 | 投稿命中率:50.0
经验分享：2015/10/22投稿次日under review，到现在一直是under review，已经5个多月了，审稿不是一般的慢，不建议大家投该杂志。

291 0

[GetPortalCommentsPageByObjectIdResponse(id=2205386, encodeId=85652205386b8, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学;生物信息学;肿瘤 经验分享：23.10.28 首次投稿 24.1.19 返回2个审稿意见要求补充一点分析，算是小修，给了8周时间 24.2.24 修回 24.3.16 接收 24.4.11 proof 24.4.15 online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bad8649258, createdName=ms1000001760489592, createdTime=Sat May 18 16:47:42 CST 2024, time=2024-05-18, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=1088045, encodeId=b83e1088045eb, content=怎么撰写引言？区别于讨论？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088046, encodeId=88f91088046ff, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569410, encodeId=993956941069, content=18年底的已经发了，审稿很严格，效率很高。毛毛1992 2017-03-21 发表:: 研究方向：靶向给药;菌膜; 接收率：约25% 审稿时间：约2个月 SCI(2015)：1.429 审了20天状态终于从pending assign editor变成了under review 不知道是有审稿人开始审稿了还是仅仅只是编剧点开了看一下不过我看这个杂志已经积压了很多稿件了现在还在发15年接收的稿子估计很悬毛毛1992 2017-03-21 09:33:00 发表: 审了20天状态终于从pending assign editor变成了under review 不知道是有审稿人开始审稿了还是仅仅只是编剧点开了看一下不过我看这个杂志已经积压了很多稿件了现在还在发15年接收的稿子估计很悬, beContent=毛毛1992 2017-03-21 发表:: 研究方向：靶向给药;菌膜; 接收率：约25% 审稿时间：约2个月 SCI(2015)：1.429 审了20天状态终于从pending assign editor变成了under review 不知道是有审稿人开始审稿了还是仅仅只是编剧点开了看一下不过我看这个杂志已经积压了很多稿件了现在还在发15年接收的稿子估计很悬, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/10/817fff867869bdbb384cc9b009479e6e.jpg, createdBy=c3d240708, createdName=quan12zf, createdTime=Thu Apr 11 00:00:00 CST 2019, time=2019-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839634, encodeId=182283963489, content=巨慢，而且给编辑写过几次信都是石沉大海。with editor状态就大概一个月，问什么时候送审没有回信，第二次是投稿3个多月的时候询问结果，也没有收到回复。四个月后终于来意见让修改，8周的修改期限，快到期时写信申请延期也没有回信。由于要求补实验数据还要送到专业机构润色语言，改了差不多三个月，修回时由于系统里面提交修改稿的通道已经关闭，只好作为新稿件提交，谁知提交后马上就收到邮件说请不要作为新稿件提交，同时给开通了原稿件的提交修改稿通道。修回后又等了将近一个月才接收。总之，如果不着急又没有更合适的期刊的可以投这个，要是着急等着用文章毕业的，这个期刊急死你没商量，而且催也不搭理的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=747c5414139, createdName=ms8486473624116251, createdTime=Thu Nov 30 10:51:14 CST 2017, time=2017-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541288, encodeId=7cc5541288f0, content=马马虎虎，能毕业就行，我师兄去年发表了一篇，也算成功毕业，就万事大吉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=huabing, createdTime=Fri Jul 14 18:46:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534499, encodeId=ba1453449929, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：审了20天状态终于从pending assign editor变成了under review 不知道是有审稿人开始审稿了还是仅仅只是编剧点开了看一下不过我看这个杂志已经积压了很多稿件了现在还在发15年接收的稿子估计很悬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d8fa1676916, createdName=毛毛1992, createdTime=Tue Mar 21 09:33:00 CST 2017, time=2017-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519663, encodeId=4a7751966325, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：2015/10/22投稿次日under review，到现在一直是under review，已经5个多月了，审稿不是一般的慢，不建议大家投该杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3b61629813, createdName=chunji1990, createdTime=Sat Feb 27 10:09:00 CST 2016, time=2016-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518883, encodeId=f52e5188838b, content=楼下说的上海的教授应该就是上海交大的钟建江老师。这位老师还是很严谨的一个老师，也比较客观公正。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa331680241, createdName=yuanfen123, createdTime=Fri Jan 29 17:46:00 CST 2016, time=2016-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505532, encodeId=7d7f50553268, content=审稿速度:2.0 经验分享：7月13日投稿，8月21日大修。三个审稿人，总共11条意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=353, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200811/5cde539c2b5a4674a6479f294173176f/e76541cf0e0f4a2188730c98d2e6be92.jpg, createdBy=ad4d88222, createdName=dswjhs, createdTime=Sat Aug 23 12:23:00 CST 2014, time=2014-08-23, status=1, ipAttribution=)]

2016-01-29 yuanfen123

楼下说的上海的教授应该就是上海交大的钟建江老师。这位老师还是很严谨的一个老师，也比较客观公正。

360 0

[GetPortalCommentsPageByObjectIdResponse(id=2205386, encodeId=85652205386b8, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学;生物信息学;肿瘤 经验分享：23.10.28 首次投稿 24.1.19 返回2个审稿意见要求补充一点分析，算是小修，给了8周时间 24.2.24 修回 24.3.16 接收 24.4.11 proof 24.4.15 online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bad8649258, createdName=ms1000001760489592, createdTime=Sat May 18 16:47:42 CST 2024, time=2024-05-18, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=1088045, encodeId=b83e1088045eb, content=怎么撰写引言？区别于讨论？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088046, encodeId=88f91088046ff, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569410, encodeId=993956941069, content=18年底的已经发了，审稿很严格，效率很高。毛毛1992 2017-03-21 发表:: 研究方向：靶向给药;菌膜; 接收率：约25% 审稿时间：约2个月 SCI(2015)：1.429 审了20天状态终于从pending assign editor变成了under review 不知道是有审稿人开始审稿了还是仅仅只是编剧点开了看一下不过我看这个杂志已经积压了很多稿件了现在还在发15年接收的稿子估计很悬毛毛1992 2017-03-21 09:33:00 发表: 审了20天状态终于从pending assign editor变成了under review 不知道是有审稿人开始审稿了还是仅仅只是编剧点开了看一下不过我看这个杂志已经积压了很多稿件了现在还在发15年接收的稿子估计很悬, beContent=毛毛1992 2017-03-21 发表:: 研究方向：靶向给药;菌膜; 接收率：约25% 审稿时间：约2个月 SCI(2015)：1.429 审了20天状态终于从pending assign editor变成了under review 不知道是有审稿人开始审稿了还是仅仅只是编剧点开了看一下不过我看这个杂志已经积压了很多稿件了现在还在发15年接收的稿子估计很悬, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/10/817fff867869bdbb384cc9b009479e6e.jpg, createdBy=c3d240708, createdName=quan12zf, createdTime=Thu Apr 11 00:00:00 CST 2019, time=2019-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839634, encodeId=182283963489, content=巨慢，而且给编辑写过几次信都是石沉大海。with editor状态就大概一个月，问什么时候送审没有回信，第二次是投稿3个多月的时候询问结果，也没有收到回复。四个月后终于来意见让修改，8周的修改期限，快到期时写信申请延期也没有回信。由于要求补实验数据还要送到专业机构润色语言，改了差不多三个月，修回时由于系统里面提交修改稿的通道已经关闭，只好作为新稿件提交，谁知提交后马上就收到邮件说请不要作为新稿件提交，同时给开通了原稿件的提交修改稿通道。修回后又等了将近一个月才接收。总之，如果不着急又没有更合适的期刊的可以投这个，要是着急等着用文章毕业的，这个期刊急死你没商量，而且催也不搭理的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=747c5414139, createdName=ms8486473624116251, createdTime=Thu Nov 30 10:51:14 CST 2017, time=2017-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541288, encodeId=7cc5541288f0, content=马马虎虎，能毕业就行，我师兄去年发表了一篇，也算成功毕业，就万事大吉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=huabing, createdTime=Fri Jul 14 18:46:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534499, encodeId=ba1453449929, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：审了20天状态终于从pending assign editor变成了under review 不知道是有审稿人开始审稿了还是仅仅只是编剧点开了看一下不过我看这个杂志已经积压了很多稿件了现在还在发15年接收的稿子估计很悬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d8fa1676916, createdName=毛毛1992, createdTime=Tue Mar 21 09:33:00 CST 2017, time=2017-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519663, encodeId=4a7751966325, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：2015/10/22投稿次日under review，到现在一直是under review，已经5个多月了，审稿不是一般的慢，不建议大家投该杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3b61629813, createdName=chunji1990, createdTime=Sat Feb 27 10:09:00 CST 2016, time=2016-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518883, encodeId=f52e5188838b, content=楼下说的上海的教授应该就是上海交大的钟建江老师。这位老师还是很严谨的一个老师，也比较客观公正。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa331680241, createdName=yuanfen123, createdTime=Fri Jan 29 17:46:00 CST 2016, time=2016-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505532, encodeId=7d7f50553268, content=审稿速度:2.0 经验分享：7月13日投稿，8月21日大修。三个审稿人，总共11条意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=353, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200811/5cde539c2b5a4674a6479f294173176f/e76541cf0e0f4a2188730c98d2e6be92.jpg, createdBy=ad4d88222, createdName=dswjhs, createdTime=Sat Aug 23 12:23:00 CST 2014, time=2014-08-23, status=1, ipAttribution=)]

2014-08-23 dswjhs

审稿速度:2.0
经验分享：7月13日投稿，8月21日大修。三个审稿人，总共11条意见。

353 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务